Skip to main content
Have a personal or library account? Click to login
Sex Disparities in Cardiovascular Disease Cover

References

  1. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998 Apr 4;316(7137):1043-7. doi: 10.1136/bmj.316.7137.1043
  2. Trinidad DR, Pérez-Stable EJ, Emery SL, White MM, Grana RA, Messer KS. Intermittent and light daily smoking across racial/ethnic groups in the United States. Nicotine Tob Res. 2009 Feb;11(2):203-10. doi: 10.1093/ntr/ntn018
  3. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32. doi: 10.1016/j.jacc.2010.05.034
  4. Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014 Aug;57(8):1542-51. doi: 10.1007/s00125-014-3260-6
  5. Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019 May;15(5):288-298. doi: 10.1038/s41574-019-0176-8
  6. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief. 2017 Oct:(288):1-8. PMID: 29155689
  7. Wenger NK, Arnold A, Bairey Merz CN, et al. Hypertension across a woman’s life cycle. J Am Coll Cardiol. 2018 Apr 24;71(16):1797-1813. doi: 10.1016/j.jacc.2018.02.033
  8. Mehta L, Velarde G, Lewey J, et al. American Heart Association Cardiovascular Disease and Stroke in Women and Underrepresented Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Hypertension; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Stroke Council. Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement from the American Heart Association. Circulation. 2023 May 9;147(19):1471-1487. doi: 10.1161/CIR.0000000000001139
  9. Holven KB, van Lennep JR. Sex differences in lipids: a life course approach. Atherosclerosis. 2023 Nov;384::117270. doi: 10.1016/j.atherosclerosis.2023.117270
  10. Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005 Nov 22;112(21):3337-47. doi: 10.1161/CIRCULATIONAHA.104.507996
  11. Ohman RE, Yang EH, Abel ML. Inequity in Cardio-Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes. J Am Heart Assoc. 2021 Dec 21;10(24):e023852. doi: 10.1161/JAHA.121.023852
  12. Jain V, Al Rifai M, Turpin R, et al. Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-Reported Premature Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2022 Mar 1;7(3):341-345. doi: 10.1001/jamacardio.2021.5430
  13. Zhu F, Qi H, Bos M, Boersma E, Kavousi M. Female Reproductive Factors and Risk of New-Onset Heart Failure: Findings From UK Biobank. JACC Heart Fail. 2023 Sep;11(9):1203-1212. doi: 10.1016/j.jchf.2023.02.019
  14. O’Kelly AC, Michos ED, Shufelt CL, et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res. 2022 Feb 18;130(4):652-672. doi: 10.1161/CIRCRESAHA.121.319895
  15. Guan C, Zahid S, Minhas AS, et al. Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease. Fertil Steril. 2022 May;117(5):924-935. doi: 10.1016/j.fertnstert.2022.03.009
  16. Lau ES, Wang D, Roberts M, et al. Infertility and risk of heart failure in the Women’s Health Initiative. J Am Coll Cardiol. 2022 Apr 26;79(16):1594-1603. doi: 10.1016/j.jacc.2022.02.020
  17. Wang Y-X, Mínguez-Alarcón L, Gaskins AJ, et al. Pregnancy loss and risk of cardiovascular disease: the Nurses’ Health Study II. Eur Heart J. 2022 Jan 25;43(3):190-199. doi: 10.1093/eurheartj/ehab737
  18. Li W, Ruan W, Lu Z, Wang D. Parity and risk of maternal cardiovascular disease: a dose–response meta-analysis of cohort studies. Eur J Prev Cardiol. 2019 Apr;26(6):592-602. doi: 10.1177/2047487318818265
  19. Grandi SM, Filion KB, Yoon S, et al. Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications. Circulation. 2019 Feb 19;139(8):1069-1079. doi: 10.1161/CIRCULATIONAHA.118.036748
  20. Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021 Jun 19;397(10292):2385-2438. doi: 10.1016/S0140-6736(21)00684-X
  21. Lichtman JH, Leifheit EC, Safdar B, et al. Sex Differences in the Presentation and Perception of Symptoms Among Young Patients With Myocardial Infarction: Evidence from the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients). Circulation. 2018 Feb 20;137(8):781-790. doi: 10.1161/CIRCULATIONAHA.117.031650
  22. Murphy AC, Yudi MB, Farouque O, et al. Impact of gender and door-to-balloon times on long-term mortality in patients presenting with ST-elevation myocardial infarction. Am J Cardiol. 2019 Sep 15;124(6):833-841. doi: 10.1016/j.amjcard.2019.06.008
  23. Stehli J, Martin C, Brennan A, Dinh DT, Lefkovits J, Zaman S. Sex differences persist in time to presentation, revascularization, and mortality in myocardial infarction treated with percutaneous coronary intervention. J Am Heart Assoc. 2019 May 21;8(10):e012161. doi: 10.1161/JAHA.119.012161
  24. Solhpour A, Chang KW, Arain SA, et al. Ischemic time is a better predictor than door-to-balloon time for mortality and infarct size in ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2016 Jun;87(7):1194-200. doi: 10.1002/ccd.26230
  25. Yiadom MYA, Gong W, Patterson BW, et al. Fallacy of Median Door-to-ECG Time: Hidden Opportunities for STEMI Screening Improvement. J Am Heart Assoc. 2022 May 3;11(9):e024067. doi: 10.1161/JAHA.121.024067
  26. Banco D, Chang J, Talmor N, et al. Sex and race differences in the evaluation and treatment of young adults presenting to the emergency department with chest pain. J Am Heart Assoc. 2022 May 17;11(10):e024199. doi: 10.1161/JAHA.121.024199
  27. Huded CP, Johnson M, Kravitz K, et al. 4-step protocol for disparities in STEMI care and outcomes in women. J Am Coll Cardiol. 2018 May 15;71(19):2122-32. doi: 10.1016/j.jacc.2018.02.039
  28. Potts J, Sirker A, Martinez SC, et al. Persistent sex disparities in clinical outcomes with percutaneous coronary intervention: insights from 6.6 million PCI procedures in the United States. PLoS One. 2018 Sep 4;13(9):e0203325. doi: 10.1371/journal.pone.0203325
  29. Seegers LM, Araki M, Nakajima A, et al. Sex differences in culprit plaque characteristics among different age groups in patients with acute coronary syndromes. Circ Cardiovasc Interv. 2022 Jun;15(6):e011612. doi: 10.1161/CIRCINTERVENTIONS.121.011612
  30. Guagliumi G, Capodanno D, Saia F, et al. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study. JACC Cardiovasc Interv. 2014 Sep;7(9):958-68. doi: 10.1016/j.jcin.2014.05.011
  31. Mahowald MK, Alqahtani F, Alkhouli M. Comparison of Outcomes of Coronary Revascularization for Acute Myocardial Infarction in Men Versus Women. Am J Cardiol. 2020 Oct 1;132:1-7. doi: 10.1016/j.amjcard.2020.07.014
  32. Hao Y, Liu J, Liu J, et al. Sex differences in in-hospital management and outcomes of patients with acute coronary syndrome. Circulation. 2019 Apr 9;139(15):1776-1785. doi: 10.1161/CIRCULATIONAHA.118.037655
  33. Glaser R, Herrmann HC, Murphy SA, et al. Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA. 2002 Dec 25;288(24):3124-9. doi: 10.1001/jama.288.24.3124
  34. Smilowitz NR, Mahajan AM, Roe MT, et al. Mortality of myocardial infarction by sex, age, and obstructive coronary artery disease status in the ACTION Registry–GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With the Guidelines). Circ Cardiov Qual Outcomes. 2017 Dec;10(12):e003443. doi: 10.1161/CIRCOUTCOMES.116.003443
  35. Lindahl B, Baron T, Erlinge D, et al. Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease. Circulation. 2017 Apr 18;135(16):1481-1489. doi: 10.1161/CIRCULATIONAHA.116.026336
  36. Reynolds HR, Shaw LJ, Min JK, et al. Association of sex with severity of coronary artery disease, ischemia, and symptom burden in patients with moderate or severe ischemia: secondary analysis of the ISCHEMIA randomized clinical trial. JAMA Cardiol. 2020 Jul 1;5(7):773-786. doi: 10.1001/jamacardio.2020.0822
  37. Lansky AJ, Ng VG, Maehara A, et al. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC Cardiovasc Imaging. 2012 Mar;5(3 Suppl):S62-72. doi: 10.1016/j.jcmg.2012.02.003
  38. Kim SG, Apple S, Mintz GS, et al. The importance of gender on coronary artery size: In-vivo assessment by intravascular ultrasound. Clin Cardiol. 2004 May;27(5):291-4. doi: 10.1002/clc.4960270511
  39. Herscovici R, Sedlak T, Wei J, Pepine CJ, Handberg E, Bairey Merz CN. Ischemia and no obstructive coronary artery disease (INOCA): what is the risk? J Am Heart Assoc. 2018 Sep 4;7(17):e008868. doi: 10.1161/JAHA.118.008868
  40. Jawitz OK, Lawton JS, Thibault D, et al. Sex Differences in Coronary Artery Bypass Grafting Techniques: A Society of Thoracic Surgeons Database Analysis. Ann Thorac Surg. 2022 Jun;113(6):1979-1988. doi: 10.1016/j.athoracsur.2021.06.039
  41. Roques F, Nashef S, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999 Jun;15(6):816-22; discussion 822-3. doi: 10.1016/s1010-7940(99)00106-2
  42. Shahian DM, Jacobs JP, Badhwar V, et al. The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models: Part 1—Background, Design Considerations, and Model Development. Ann thorac Surg. 2018 May;105(5):1411-1418. doi: 10.1016/j.athoracsur.2018.03.002
  43. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non–ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000 Aug 16;284(7):835-42. doi: 10.1001/jama.284.7.835
  44. Six A, Backus B, Kelder J. Chest pain in the emergency room: value of the HEART score. Neth Heart J. 2008 Jun;16(6):191-6. doi: 10.1007/BF03086144
  45. Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006 Nov 25;333(7578):1091. doi: 10.1136/bmj.38985.646481.55
  46. Sanders KM, Nacario JH, Smith EJ, et al. Structured discharge documentation reduces sex-based disparities in statin prescription in vascular surgery patients. J Vasc Surg. 2023 May;77(5):1504-1511. doi: 10.1016/j.jvs.2023.01.179
  47. de Bakker M, Anand A, Shipley M, et al. Sex Differences in Cardiac Troponin Trajectories Over the Life Course. Circulation. 2023 Jun 13;147(24):1798-1808. doi: 10.1161/CIRCULATIONAHA.123.064386
  48. Shaw LJ, Min JK, Nasir K, et al. Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium. Eur Heart J. 2018 Nov 1;39(41):3727-3735. doi: 10.1093/eurheartj/ehy534
  49. DeFilippis EM, Beale A, Martyn T, et al. Heart failure subtypes and cardiomyopathies in women. Circ Res. 2022 Feb 18;130(4):436-54. doi: 10.1161/CIRCRESAHA.121.319900
  50. Bozkurt B, Khalaf S. Heart Failure in Women. Methodist Debakey Cardiovasc J. 2017;13(4):216-23. doi: 10.14797/mdcj-13-4-216
  51. Lam CSP, Arnott C, Beale AL, et al. Sex differences in heart failure. Eur Heart J. 2019;40(47):3859-68c. doi: 10.1093/eurheartj/ehz835
  52. Sohani ZN, Behlouli H, de Moura CS, Abrahamowicz M, Pilote L. Sex Differences in the Effectiveness of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Sacubitril–Valsartan for the Treatment of Heart Failure. J Am Heart Assoc. 2023 Jul 18;12(14):e028865. doi: 10.1161/JAHA.122.028865
  53. Eugene AR. Gender based Dosing of Metoprolol in the Elderly using Population Pharmacokinetic Modeling and Simulations. Int J Clin Pharmacol Toxicol. 2016 May;5(3):209-15. doi: 10.19070/2167-910X-1600035
  54. Israili ZH. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. J Hum Hypertens. 2000 Apr;14 Suppl 1:S73-86. doi: 10.1038/sj.jhh.1000991
  55. Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48(3):143-57. doi: 10.2165/00003088-200948030-00001
  56. Lund LH, Braunschweig F, Benson L, Ståhlberg M, Dahlström U, Linde C. Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry. Eur J Heart Fail. 2017;19(10):1270-9. doi: 10.1002/ejhf.781
  57. Leyva F, Qiu T, Zegard A, et al. Sex-Specific Differences in Survival and Heart Failure Hospitalization After Cardiac Resynchronization Therapy With or Without Defibrillation. J Am Heart Assoc. 2019 Nov 19;8(22):e013485. doi: 10.1161/jaha.119.013485
  58. Amuthan R, Curtis AB. Sex-Specific Considerations in Drug and Device Therapy of Cardiac Arrhythmias: JACC Focus Seminar 6/7. J Am Coll Cardiol. 2022 Apr 19;79(15):1519-29. doi: 10.1016/j.jacc.2021.11.066
  59. Bhardwaj A, Kumar S, Park JK, et al. Gender Inequality in Use of Percutaneous Mechanical Circulatory Support in Patients With Cardiogenic Shock-Call For Action. J Am Coll Cardiol. 2023 Mar;81(8_Supplement):725. doi: 10.1016/S0735-1097(23)01169-5
  60. Joshi AA, Lerman JB, Sajja AP, et al. Sex-based differences in left ventricular assist device utilization: insights from the nationwide inpatient sample 2004 to 2016. Circ Heart Fail. 2019 Sep;12(9):e006082. doi: 10.1161/CIRCHEARTFAILURE.119.006082
  61. Moayedi Y, Fan CPS, Cherikh WS, et al. Survival outcomes after heart transplantation: does recipient sex matter? Circ Heart Fail. 2019 Oct;12(10):e006218. doi: 10.1161/CIRCHEARTFAILURE.119.006218
  62. Oliveros E, Saldarriaga Giraldo CI, Hall J, et al. Addressing Barriers for Women with Advanced Heart Failure. Curr Cardiol Rep. 2023 Oct;25(10):1257-1267. doi: 10.1007/s11886-023-01946-y
  63. Mou L, Norby FL, Chen LY, et al. Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (Atherosclerosis Risk in Communities). Circ Arrhythm Electrophysiol. 2018 Jul;11(7):e006350. doi: 10.1161/CIRCEP.118.006350
  64. Lip GY, Laroche C, Boriani G, et al. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. Europace. 2015 Jan;17(1):24-31. doi: 10.1093/europace/euu155
  65. Emdin CA, Wong CX, Hsiao AJ, et al. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ. 2016 Jan 19;352:h7013. doi: 10.1136/bmj.h7013
  66. Tse HF, Oral H, Pelosi F, Knight BP, Strickberger SA, Morady F. Effect of gender on atrial electrophysiologic changes induced by rapid atrial pacing and elevation of atrial pressure. J Cardiovasc Electrophysiol. 2001 Sep;12(9):986-9. doi: 10.1046/j.1540-8167.2001.00986.x
  67. Cochet H, Mouries A, Nivet H, et al. Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population. J Cardiovasc Electrophysiol. 2015 May;26(5):484-92. doi: 10.1111/jce.12651
  68. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612
  69. Patel D, Mohanty P, Di Biase L, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm. 2010;7(2):167-72. doi: 10.1016/j.hrthm.2009.10.025
  70. Volgman AS, Benjamin EJ, Curtis AB, et al. Women and atrial fibrillation. J Cardiovasc Electrophysiol. 2021 Oct;32(10):2793-2807. doi: 10.1111/jce.14838
  71. Sullivan RM, Zhang J, Zamba G, Lip GY, Olshansky B. Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). Am J Cardiol. 2012 Dec 15;110(12):1799-802. doi: 10.1016/j.amjcard.2012.08.014
  72. Pancholy SB, Sharma PS, Pancholy DS, Patel TM, Callans DJ, Marchlinski FE. Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants. Am J Cardiol. 2014 Feb 1;113(3):485-90. doi: 10.1016/j.amjcard.2013.10.035
  73. Holmes DR, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014 Jul 8;64(1):1-12. doi: 10.1016/j.jacc.2014.04.029
  74. Reddy VY, Doshi SK, Kar S, et al. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol. 2017 Dec 19;70(24):2964-2975. doi: 10.1016/j.jacc.2017.10.021
  75. Prosperi-Porta G, Nguyen V, Willner N, et al. Association of age and sex with use of transcatheter aortic valve replacement in France. J Am Coll Cardiol. 2023 Nov 14;82(20):1889-1902. doi: 10.1016/j.jacc.2023.08.044
  76. Bienjonetti-Boudreau D, Fleury M-A, Voisine M, et al. Impact of sex on the management and outcome of aortic stenosis patients. Eur Heart J. 2021 Jul 15;42(27):2683-2691. doi: 10.1093/eurheartj/ehab242
  77. Iribarren AC, AlBadri A, Wei J, et al. Sex differences in aortic stenosis: Identification of knowledge gaps for sex-specific personalized medicine. Am Heart J Plus. 2022 Sep;21:100197. doi: 10.1016/j.ahjo.2022.100197
  78. Martin J, Coffey S, Whalley GA. Sex disparity in cardiovascular disease outcomes: do our current echocardiographic reference ranges measure up? Heart, Lung Circ. 2021 Jan;30(1):e1-e5. doi: 10.1016/j.hlc.2020.10.004
  79. Chandrasekhar J, Dangas G, Yu J, et al. Sex-based differences in outcomes with transcatheter aortic valve therapy: TVT registry from 2011 to 2014. J Am Coll Cardiol. 2016 Dec 27;68(25):2733-2744. doi: 10.1016/j.jacc.2016.10.041
  80. Chugh Y, Mahowald MK, Robert J, Bradley SM, Gössl M. Identifying and Addressing Gaps in the Care of Patients With Severe Valve Disease. Circ Cardiovas Qual Outcomes. 2022 Dec;15(12):e009209. doi: 10.1161/CIRCOUTCOMES.122.009209
  81. Beery AK, Zucker I. Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev. 2011 Jan;35(3):565-72. doi: 10.1016/j.neubiorev.2010.07.002
  82. Reddy KP, Faggioni M, Eberly LA, et al. Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review. JAMA Cardiol. 2023 Sep 1;8(9):871-878. doi: 10.1001/jamacardio.2023.2098
  83. Morgan H, Sinha A, Mcentegart M, Hardman SM, Perera D. Evaluation of the causes of sex disparity in heart failure trials. Heart. 2022 Sep 12;108(19):1547-1552. doi: 10.1136/heartjnl-2021-320696
  84. Scott PE, Unger EF, Jenkins MR, et al. Participation of women in clinical trials supporting FDA approval of cardiovascular drugs. J Am Coll Cardiol. 2018 May 8;71(18):1960-1969. doi: 10.1016/j.jacc.2018.02.070
  85. Gong IY, Tan NS, Ali SH, et al. Temporal trends of women enrollment in major cardiovascular randomized clinical trials. Can J Cardiol. 2019 May;35(5):653-660. doi: 10.1016/j.cjca.2019.01.010
  86. Matthews S, Cook S, Clayton T, Murray S, Wynne R, Sanders J. Factors Affecting Women’s Participation in Cardiovascular Research: A Scoping Review. Eur J Cardiovasc Nurs. 2023 May 18:zvad048. doi: 10.1093/eurjcn/zvad048
  87. Mehta LS, Fisher K, Rzeszut AK, et al. Current Demographic Status of Cardiologists in the United States. JAMA Cardiol. 2019 Oct 1;4(10):1029-1033. doi: 10.1001/jamacardio.2019.3247
  88. Shahid M. Addressing the Underrepresentation of Women in Cardiology through Tangible Opportunities for Mentorship and Leadership. Methodist Debakey Cardiovasc J. 2019 Jan-Mar;15(1):e1-e2. doi: 10.14797/mdcj-15-1-e1
  89. Blumenthal DM, Olenski AR, Yeh RW, et al. Sex Differences in Faculty Rank Among Academic Cardiologists in the United States. Circulation. 2017 Feb 7;135(6):506-517. doi: 10.1161/circulationaha.116.023520
  90. Whitelaw S, Thabane L, Mamas MA, et al. Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors. J Am Coll Cardiol. 2020 Oct 27;76(17):1919-1930. doi: 10.1016/j.jacc.2020.08.062
  91. Blumer V, Zhbannikov IY, Douglas PS. Contributions of Women to Cardiovascular Science Over Two Decades: Authorship, Leadership, and Mentorship. J Am Heart Assoc. 2023 Ma;12(5):e026828. doi: 10.1161/jaha.122.026828
  92. Asghar M, Usman MS, Aibani R, et al. Sex Differences in Authorship of Academic Cardiology Literature Over the Last 2 Decades. J Am Coll Cardiol. 2018 Aug 7;72(6):681-685. doi: 10.1016/j.jacc.2018.05.047
  93. Mehran R, Kumar A, Bansal A, Shariff M, Gulati M, Kalra A. Gender and Disparity in First Authorship in Cardiology Randomized Clinical Trials. JAMA Netw Open. 2021 Mar 1;4(3):e211043. doi: 10.1001/jamanetworkopen.2021.1043
  94. Pinho-Gomes AC, Vassallo A, Thompson K, Womersley K, Norton R, Woodward M. Representation of Women Among Editors in Chief of Leading Medical Journals. JAMA Netw Open. 2021 Sep 1;4(9):e2123026. doi: 10.1001/jamanetworkopen.2021.23026
  95. Balasubramanian S, Saberi S, Yu S, Duvernoy CS, Day SM, Agarwal PP. Women Representation Among Cardiology Journal Editorial Boards. Circulation. 2020 Feb 18;141(7):603-605. doi: 10.1161/circulationaha.119.042909
DOI: https://doi.org/10.14797/mdcvj.1328 | Journal eISSN: 1947-6108
Language: English
Page range: 107 - 119
Submitted on: Dec 19, 2023
Accepted on: Jan 30, 2024
Published on: Mar 14, 2024
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2024 Madeline K. Mahowald, Khadeeja Esmail, Fatima M. Ezzeddine, Calvin Choi, Hanna Mieszczanska, Gladys Velarde, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.